Skip to main content
. 2016 Sep 1;6(9):160. doi: 10.3390/nano6090160

Figure 5.

Figure 5

Activity of AgNPs against human pathogen: (a) E. coli; (b) S. aureus; (c) S. paratyphi B; and (d) B. subtilis, depicting zones of inhibition of: 128 μg/mL (1); 32 μg/mL (2); 8 μg/mL (3); 2 μg/mL (4); 1699 μg/mL AgNO3 control (5); and 1 mM gentamycin sulfate (6).